Condition
Pleural Neoplasms
Estimated Enrollment: 77
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: 7216|H3E-US-JMGA
Study First Received: July 12, 2004
Last Updated: May 1, 2009
Estimated Primary Completion Date: February 2008
Primary Outcome Measures:
Pathological Complete Response|The 1 and 2 Year Disease-Free Survival Rate (Percentage)|Overall Tumor Response|Time to Treatment Failure|Time to Progressive Disease|Overall Survival Time
Sponsors and Collaborators:
Eli Lilly and Company
Website Link: https://ClinicalTrials.gov/show/NCT00087698
